STIM
Neuronetics Inc
2.20$
-5.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +24.6% | -10.4% | -6.7% | -23.4% | +90.1% | +0.8% | -5.2% | +8.0% | -2.7% | -11.4% | +4.9% | |
| – | +32.1% | -12.7% | -7.8% | -29.2% | +8.7% | +4.4% | -7.5% | +15.6% | -5.1% | -23.4% | +12.8% | |
| – | +66.5% | -20.0% | -10.7% | -51.1% | -6.7% | +9.1% | -17.7% | +97.3% | -1.0% | -61.3% | +45.3% | |
| – | +64.6% | -19.9% | -10.8% | -50.5% | -8.3% | +9.0% | -17.6% | +96.4% | -0.8% | -61.5% | +47.0% | |
| – | +5.7% | +10.0% | -0.6% | -1.0% | +25.8% | +10.7% | -0.9% | -28.0% | -12.0% | -4.9% | +1.3% | |
| – | -16.9% | -17.3% | -8.2% | -19.2% | -14.4% | -4.2% | +21.5% | -12.6% | +0.1% | +9.0% | +16.7% | |
| – | – | – | – | – | – | +0.0% | +2.4% | +18.8% | +4.2% | +0.0% | +0.0% | |
| – | – | – | – | – | – | -1.9% | -1.9% | +1.2% | -5.0% | -2.0% | -2.1% | |
| – | +48.3% | -6.7% | +1.7% | -16.4% | +68.5% | -6.1% | +0.7% | +10.6% | +1.1% | -6.0% | +1.4% | |
| – | +29.2% | -26.8% | +101.8% | -42.2% | +85.0% | -20.5% | +11.9% | +4.1% | +5.5% | -7.3% | +0.1% | |
| – | +0.6% | +0.7% | +1,600.1% | -94.0% | +455.8% | +2.7% | +8.0% | +5.0% | -0.4% | -2.5% | -5.1% | |
| – | +68.4% | -37.3% | +37.7% | -19.7% | +236.2% | -23.4% | +14.7% | +19.0% | -7.2% | +6.5% | +8.6% | |
| – | +60.9% | +0.3% | -22.4% | -0.3% | +19.9% | +0.3% | +0.4% | +18.2% | +0.2% | -6.9% | +0.4% | |
| – | -9.9% | -19.1% | -29.9% | -51.6% | +195.3% | +28.0% | -23.4% | +0.8% | -18.2% | -40.7% | +34.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.6% | +1.5% | +2.0% | +0.7% | +21.2% | +67.6% | +7.7% | +1.7% | +2.1% | +1.2% | +2.6% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.